As underlined by Allred in an editorial on problems and solutions in the evaluation of hormone receptors in breast cancers [32], there is no reason to expect similar results or performance from two different tests measuring either protein or mRNA expression, despite the fact that studies have found good concordance results especially for ER status between the two methods [10, 11]. The gene discussed is ESR1; the disease is breast cancer.